Compare OPK & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPK | NX |
|---|---|---|
| Founded | 2006 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 921.2M | 742.7M |
| IPO Year | 2011 | 2008 |
| Metric | OPK | NX |
|---|---|---|
| Price | $1.21 | $19.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $2.03 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 2.3M | 493.7K |
| Earning Date | 05-29-2026 | 03-12-2026 |
| Dividend Yield | N/A | ★ 1.57% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $606,879,000.00 | ★ $1,837,641,000.00 |
| Revenue This Year | N/A | $3.18 |
| Revenue Next Year | $8.75 | $2.27 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 43.81 |
| 52 Week Low | $1.11 | $11.04 |
| 52 Week High | $2.04 | $22.90 |
| Indicator | OPK | NX |
|---|---|---|
| Relative Strength Index (RSI) | 46.64 | 42.05 |
| Support Level | $1.12 | $18.32 |
| Resistance Level | $1.27 | $19.88 |
| Average True Range (ATR) | 0.04 | 0.81 |
| MACD | 0.01 | -0.42 |
| Stochastic Oscillator | 60.71 | 6.52 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.